id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-281703-6xwcxe8l	Di Altobrando, Ambra	Should SARS‐CoV‐2 influence immunosuppressive therapy for autoimmune blistering diseases?	2020-04-17		.txt	text/plain	999	32	30	Therefore, it will be crucial for our community to learn of more cases of autoimmune bullous disease patients under immunosuppressive treatment who have developed COVID-19, in order to better quantify the risk of infection under immunosuppressive therapy. But what about patients already in immunosuppressive therapy for these potentially life-threatening disorders?	cache/cord-281703-6xwcxe8l.txt	txt/cord-281703-6xwcxe8l.txt
